Great Britain will begin the rollout of the Pfizer COVID-19 pill in February, the United Kingdom Department of Health and Social Care announced Friday.
The pill will be available to those with “weakened immune systems” beginning on February 10th.
As previously reported by Human Events News, Pfizer announced earlier this month that its COVID-19 pill, Paxlovid, is effective against the omicron variant.
The company said three separate lab studies showed the main protease inhibitor in the drug, nirmatrelvir, maintains its effectiveness against the omicron variant.
The FDA in December authorized the Pfizer pill for emergency use.
Paxlovid will be prescribed for use in adults and children over the age of 12 with mild to moderate sickness who are at risk for severe disease or hospitalization.
“It is fantastic news that this new treatment, the latest cutting-edge drug that the NHS is rolling out through new COVID-19 medicine delivery units, will now be available to help those at highest risk of COVID-19,” NHS National Medical Director Professor Stephen Powis said, per The Hill.
The Pfizer pill was approved Thursday by the European Medicines Agency for use among high-risk patients in the European Union.
